Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Curr Opin Virol. 2019 Feb 10;35:1–13. doi: 10.1016/j.coviro.2018.12.009

Table 2.

Viral-Directed anti-RABV Compounds

Compound Target EC50 (uM) CC50 (uM) SI (CC50/EC50) Ref.
Ketamine vRNA Synthesis 922.93 ± 68.48 3010.69 ± 171.26 3.3 [54, 193]
Ribavirin de novo purine synthesis 18.55 >200 >10 [57]
EICAR de novo purine synthesis 0.90 >200 >200 [57]
EICNR de novo purine synthesis 3.80 >200 >50 [57]
Favipiravir vRdRp 32.4 >2500mM >1000 [60, 194]